Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer.

[1]  Andrew P McMahon,et al.  Sp7/Osterix Is Restricted to Bone-Forming Vertebrates where It Acts as a Dlx Co-factor in Osteoblast Specification. , 2016, Developmental cell.

[2]  J. Clifton,et al.  Secretome Analysis of an Osteogenic Prostate Tumor Identifies Complex Signaling Networks Mediating Cross-talk of Cancer and Stromal Cells Within the Tumor Microenvironment* , 2014, Molecular & Cellular Proteomics.

[3]  S. Fosså,et al.  Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial. , 2014, The Lancet. Oncology.

[4]  R. Kalluri,et al.  Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype. , 2012, Seminars in cancer biology.

[5]  P. Woolf,et al.  The transcription factor osterix (SP7) regulates BMP6‐induced human osteoblast differentiation , 2012, Journal of cellular physiology.

[6]  K. Pienta,et al.  Disseminated Prostate Cancer Cells Can Instruct Hematopoietic Stem and Progenitor Cells to Regulate Bone Phenotype , 2012, Molecular Cancer Research.

[7]  P. ten Dijke,et al.  Regulation of endothelial cell plasticity by TGF-β , 2011, Cell and Tissue Research.

[8]  R. Satcher,et al.  BMP4 promotes prostate tumor growth in bone through osteogenesis. , 2011, Cancer research.

[9]  Raghu Kalluri,et al.  Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. , 2011, The Biochemical journal.

[10]  Jian Q. Feng,et al.  Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice , 2010, Proceedings of the National Academy of Sciences.

[11]  C. Logothetis,et al.  Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. , 2010, Cancer research.

[12]  J. Gordon,et al.  Bone sialoprotein stimulates focal adhesion‐related signaling pathways: Role in migration and survival of breast and prostate cancer cells , 2009, Journal of cellular biochemistry.

[13]  Raymond B. Runyan,et al.  Ligand‐specific function of transforming growth factor beta in epithelial‐mesenchymal transition in heart development , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[14]  Tomokazu Fukuda,et al.  BMP type I receptor inhibition reduces heterotopic ossification , 2008, Nature Medicine.

[15]  B. Black,et al.  BMP4 is required in the anterior heart field and its derivatives for endocardial cushion remodeling, outflow tract septation, and semilunar valve development , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[16]  M. Klagsbrun,et al.  Calcification of multipotent prostate tumor endothelium. , 2008, Cancer cell.

[17]  R. Vessella,et al.  Histopathological assessment of prostate cancer bone osteoblastic metastases. , 2008, The Journal of urology.

[18]  E. Vazquez,et al.  Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. , 2008, The Journal of clinical investigation.

[19]  Hideki Yoshikawa,et al.  Circulating Bone Marrow‐Derived Osteoblast Progenitor Cells Are Recruited to the Bone‐Forming Site by the CXCR4/Stromal Cell‐Derived Factor‐1 Pathway , 2008, Stem cells.

[20]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[21]  C. Logothetis,et al.  A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells. , 2007, Cancer research.

[22]  Hong Wu,et al.  Increased expression of osteopontin contributes to the progression of prostate cancer. , 2006, Cancer research.

[23]  R. Schwartz,et al.  Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning , 2005, Development.

[24]  B. Riggs,et al.  Circulating osteoblast-lineage cells in humans. , 2005, The New England journal of medicine.

[25]  J. Polak,et al.  Osteogenic differentiation of mouse embryonic stem cells: differential gene expression analysis by cDNA microarray and purification of osteoblasts by cadherin-11 magnetically activated cell sorting. , 2004, Tissue engineering.

[26]  P. Troncoso,et al.  Up‐regulation of MDA‐BF‐1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow , 2004, The Journal of pathology.

[27]  B. Teicher,et al.  Murine Endothelial Cell Lines as Models of Tumor Endothelial Cells , 2004, Clinical Cancer Research.

[28]  H. Suemizu,et al.  Genotyping the mouse severe combined immunodeficiency mutation using the polymerase chain reaction with confronting two-pair primers (PCR-CTPP). , 2002, Experimental animals.

[29]  E. Schmidt,et al.  Molecular genotyping of the mouse scid allele. , 2002, Journal of immunological methods.

[30]  L. Chung,et al.  Regulation of Human Osteocalcin Promoter in Hormone-independent Human Prostate Cancer Cells* , 2002, The Journal of Biological Chemistry.

[31]  J. Deng,et al.  The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.

[32]  Jian Zhang,et al.  Bone metastatic LNCaP‐derivative C4‐2B prostate cancer cell line mineralizes in vitro , 2001, The Prostate.

[33]  S. Takeshita,et al.  The Transition of Cadherin Expression in Osteoblast Differentiation from Mesenchymal Cells: Consistent Expression of Cadherin‐11 in Osteoblast Lineage , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  J M Polak,et al.  Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. , 2001, Tissue engineering.

[35]  G. Karsenty,et al.  The osteoblast: a sophisticated fibroblast under central surveillance. , 2000, Science.

[36]  Raymond B. Runyan,et al.  Slug is an essential target of TGFbeta2 signaling in the developing chicken heart. , 2000, Developmental biology.

[37]  M. Webber,et al.  Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. , 1999, Cancer research.

[38]  C. Kao,et al.  Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines , 1998, International journal of cancer.

[39]  R. Coleman.  Skeletal complications of malignancy , 1997, Cancer.

[40]  B. Foster,et al.  Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. , 1997, Cancer research.

[41]  J. Rossert,et al.  Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice , 1995, The Journal of cell biology.

[42]  R. Kikuno,et al.  Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. , 1994, The Journal of biological chemistry.

[43]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[44]  P. Dijke,et al.  Regulation of endothelial cell plasticity by TGF-β , 2011, Cell and Tissue Research.

[45]  R. Kalluri,et al.  Conversion of vascular endothelial cells into multipotent stem-like cells , 2010, Nature Medicine.

[46]  C. Logothetis,et al.  Osteoblasts in prostate cancer metastasis to bone , 2005, Nature Reviews Cancer.

[47]  J. Aubin,et al.  Advances in the osteoblast lineage. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[48]  R. Markwald,et al.  Sturctural analysis of endocardial cytodifferentiation. , 1975, Developmental biology.